Intersection of Tyrosine Kinase Inhibition and Sepsis-Induced Cardiomyopathy

酪氨酸激酶抑制与脓毒症诱发性心肌病的交集

阅读:3

Abstract

This case details a 78-year-old male with a history of old myocardial infarction and chronic myeloid leukemia treated with tyrosine kinase inhibitors (TKIs). The patient presented with exertional dyspnea and was hospitalized for congestive heart failure. Following the development of a urinary tract infection, the patient exhibited signs of sepsis-induced cardiomyopathy (SIC), including myocardial injury and rapid hemodynamic deterioration, leading to death. Autopsy findings indicated SIC, characterized by neutrophil-dominant inflammatory cell infiltration and endothelial damage, which might have been exacerbated by the patient's preexisting conditions of old myocardial infarction and TKI therapy. This case underscores the multifactorial nature of SIC, suggesting that preexisting old myocardial infarction and TKI therapies can significantly impact the disease's pathogenesis and progression. It highlights the need for comprehensive management strategies in patients with complex medical histories and the importance of further research to elucidate the underlying mechanisms of SIC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。